Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Corporate & Special Sales
    • Journal Claims
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Permissions
    • Advertisers
    • Continuing Education
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Corporate & Special Sales
    • Journal Claims
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Permissions
    • Advertisers
    • Continuing Education
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • Follow JNM on Twitter
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Subscribe to our RSS feeds

targeted radionuclide therapy

  • Modeling Early Radiation DNA Damage Occurring During <sup>177</sup>Lu-DOTATATE Radionuclide Therapy
    Open Access
    Modeling Early Radiation DNA Damage Occurring During 177Lu-DOTATATE Radionuclide Therapy
    Giulia Tamborino, Yann Perrot, Marijke De Saint-Hubert, Lara Struelens, Julie Nonnekens, Marion De Jong, Mark W. Konijnenberg and Carmen Villagrasa
    Journal of Nuclear Medicine May 1, 2022, 63 (5) 761-769; DOI: https://doi.org/10.2967/jnumed.121.262610
  • You have access
    Intraarterial Peptide Receptor Radionuclide Therapy Using 90Y-DOTATOC for Hepatic Metastases of Neuroendocrine Tumors
    Courtney Lawhn-Heath, Nicholas Fidelman, Bryant Chee, Salma Jivan, Evan Armstrong, Li Zhang, Sheila Lindsay, Emily K. Bergsland and Thomas A. Hope
    Journal of Nuclear Medicine February 1, 2021, 62 (2) 221-227; DOI: https://doi.org/10.2967/jnumed.119.241273
  • Preclinical Characterization of the Radioimmunoconjugate <sup>111</sup>In or <sup>90</sup>Y-FF-21101 Against a P-Cadherin–Expressing Tumor in a Mouse Xenograft Model and a Nonhuman Primate
    Open Access
    Preclinical Characterization of the Radioimmunoconjugate 111In or 90Y-FF-21101 Against a P-Cadherin–Expressing Tumor in a Mouse Xenograft Model and a Nonhuman Primate
    Yuichi Funase, Eri Nakamura, Masamichi Kajita, Yasutaka Saito, Shinobu Oshikiri, Michi Kitano, Masahiko Tokura, Akihiro Hino and Tomoya Uehara
    Journal of Nuclear Medicine February 1, 2021, 62 (2) 232-239; DOI: https://doi.org/10.2967/jnumed.120.245837
  • Open Access
    Combination Strategies to Improve Targeted Radionuclide Therapy
    Tiffany G. Chan, Edward O’Neill, Christine Habjan and Bart Cornelissen
    Journal of Nuclear Medicine November 1, 2020, 61 (11) 1544-1552; DOI: https://doi.org/10.2967/jnumed.120.248062
  • Open Access
    177Lu-NM600 Targeted Radionuclide Therapy Extends Survival in Syngeneic Murine Models of Triple-Negative Breast Cancer
    Reinier Hernandez, Joseph J. Grudzinski, Eduardo Aluicio-Sarduy, Christopher F. Massey, Anatoly N. Pinchuk, Ariana N. Bitton, Ravi Patel, Ray Zhang, Aakarsha V. Rao, Gopal Iyer, Jonathan W. Engle and Jamey P. Weichert
    Journal of Nuclear Medicine August 1, 2020, 61 (8) 1187-1194; DOI: https://doi.org/10.2967/jnumed.119.236265
  • You have access
    Preclinical Characterization of 86/90Y-NM600 in a Variety of Murine and Human Cancer Tumor Models
    Joseph J. Grudzinski, Reinier Hernandez, Ian Marsh, Ravi B. Patel, Eduardo Aluicio-Sarduy, Jon Engle, Zachary Morris, Bryan Bednarz and Jamey Weichert
    Journal of Nuclear Medicine November 1, 2019, 60 (11) 1622-1628; DOI: https://doi.org/10.2967/jnumed.118.224808
  • You have access
    New Developments in Peptide Receptor Radionuclide Therapy
    Guillaume P. Nicolas, Alfred Morgenstern, Margret Schottelius and Melpomeni Fani
    Journal of Nuclear Medicine February 1, 2019, 60 (2) 167-171; DOI: https://doi.org/10.2967/jnumed.118.213496
  • You have access
    Advancing Targeted Radionuclide Therapy Through the National Cancer Institute’s Small Business Innovation Research Pathway
    Kaveh Zakeri, Deepa Narayanan, Greg Evans, Pataje Prasanna, Jeffrey C. Buchsbaum, Bhadrasain Vikram and Jacek Capala
    Journal of Nuclear Medicine January 1, 2019, 60 (1) 41-49; DOI: https://doi.org/10.2967/jnumed.118.214684
  • You have access
    Combined VLA-4–Targeted Radionuclide Therapy and Immunotherapy in a Mouse Model of Melanoma
    Jaeyeon Choi, Wissam Beaino, Ronald J. Fecek, Kellsye P.L. Fabian, Charles M. Laymon, Brenda F. Kurland, Walter J. Storkus and Carolyn J. Anderson
    Journal of Nuclear Medicine December 1, 2018, 59 (12) 1843-1849; DOI: https://doi.org/10.2967/jnumed.118.209510
  • You have access
    Radiolabeled (4-Fluoro-3-Iodobenzyl)Guanidine Improves Imaging and Targeted Radionuclide Therapy of Norepinephrine Transporter–Expressing Tumors
    Aiko Yamaguchi, Hirofumi Hanaoka, Tetsuya Higuchi and Yoshito Tsushima
    Journal of Nuclear Medicine May 1, 2018, 59 (5) 815-821; DOI: https://doi.org/10.2967/jnumed.117.201525
SNMMI

© 2022 Journal of Nuclear Medicine

Powered by HighWire